Algernon Announces Availability of its NP-120 Ifenprodil Drug for Compassionate Use for Coronavirus

VANCOUVER, British Columbia, March 6 (Korea Bizwire) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it will set aside some of its NP-120 (Ifenprodil) drug supply from its planned phase 2 study for idiopathic fibrosis and chronic cough, to [...]

Algernon Explores the Use of NP-120 (Ifenprodil) as a Novel Treatment for Coronavirus

VANCOUVER, British Columbia, March 6 (Korea Bizwire) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it is exploring the potential of using NP-120 (Ifenprodil) as a novel treatment for COVID-19, also known as the coronavirus. A recent independent study [...]